Cellebrite DI Ltd

Cellebrite DI Ltd(CLBT)财务数据

$11.370

+0.230 (+2.02%)收盘时

CLBT 盈利能力与利润率

Evaluating the bottom line, Cellebrite DI Ltd maintains a gross margin of 80.78%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 5.82%, while the net margin is 4.86%. These profitability ratios, combined with a Return on Equity (ROE) of 12.31%, provide a clear picture of how effectively CLBT converts its operational activities into shareholder value.

CLBT 同业对比

In the context of the broader market, CLBT competes directly with industry leaders such as NTCT and LFTO. With a market capitalization of $2.83B, it holds a leading position in the sector. When comparing efficiency, CLBT's gross margin of 80.78% stands against NTCT's 73.81% and LFTO's 76.31%. Such benchmarking helps identify whether Cellebrite DI Ltd is trading at a premium or discount relative to its financial performance.

Cellebrite DI Ltd 财务表现

Cellebrite reported a gross margin of 80.78% in Q2 2026, reflecting strong profitability despite recent challenges. However, net income has decreased significantly, with Q2 2026 net income dropping to $6.37 million from $20.74 million in Q4 2025, indicating potential issues with profitability.

Financials

FY2026Q2
YoY:
+15.77%
131.14M
Total Revenue
FY2026Q2
YoY:
-53.73%
7.63M
Operating Profit
FY2026Q2
YoY:
-67.29%
6.37M
Net Income after Tax
FY2026Q2
YoY:
-62.50%
0.03
EPS - Diluted
FY2026Q2
YoY:
-79.43%
5.96M
Free Cash Flow
FY2026Q2
YoY:
-4.28%
80.78
Gross Profit Margin - %
FY2026Q2
YoY:
-26.73%
25.00
FCF Margin - %
FY2026Q2
YoY:
-71.73%
4.86
Net Margin - %
FY2026Q2
12.45
ROIC

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易